首页> 外文期刊>Annals of Medicine and Surgery >Quality of life outcomes of patients with chronic rhinosinusitis after functional endoscopic sinus surgery, prospective cohort study
【24h】

Quality of life outcomes of patients with chronic rhinosinusitis after functional endoscopic sinus surgery, prospective cohort study

机译:功能性内镜鼻窦手术后慢性鼻-鼻窦炎患者的生活质量,前瞻性队列研究

获取原文
           

摘要

ObjectivesTo compare the outcome of patients with unilateral CRSsNP (U CRSsNP) and bilateral CRSsNP (B CRSsNP) undergoing FESS. Also, we evaluate the impact of SNOT-22 domains to predict their quality of life (QOL) outcomes and compare these factors with those of CRSwNP group, published in previous work.MethodsA prospective cohort study was performed in the hospital 20 August,66 patients who were presented between January 2016 and December 2017 were diagnosed with CRS according to guideline recommendations, and were beforehand refractory to initial medical therapy and elected to FESS. The Sino Nasal Outcome Test-22 (SNOT-22) was used to evaluate QOL.ResultsA higher significant improvement was observed between preoperative and postoperative SNOT-22 scores in U CRSsNP group [37.13?±?9.307 versus 14.11?±?8.531] and in B CRSsNP group [41.76?±?6.949 versus 18.57?±?8.495]. In the U CRSsNP group, patients having a preoperative SNOT-22 score higher than 20 points attained MCID in 88%. For the other group, patients having preoperative SNOT-22 score superior to 40 points achieved MCID in 66%. A multivariate logistic regression model found preoperative predictors that have impact on QOL outcomes.ConclusionsOutcomes from this study suggest that patients with U CRSsNP having a preoperative SNOT-22 scores between 10 and 19, and patients with B CRSsNP having a preoperative SNOT-22 scores between 10 and 19 or 20–29 had no chance of achieving an MCID improvement after FESS. Also, preoperative rhinologic symptoms and preoperative psychological dysfunction domains of SNOT-22 are helpful tools to predict improvement after FESS unlike the unilateral character of CRS.
机译:目的比较单侧CRSsNP(U CRSsNP)和双侧CRSsNP(B CRSsNP)接受FESS的患者的结局。此外,我们评估了SNOT-22域的影响以预测其生存质量(QOL),并将这些因素与先前研究中发表的CRSwNP组进行比较。方法前瞻性队列研究在医院于8月20日进行,66例患者根据指南建议,于2016年1月至2017年12月期间就诊的患者被确诊为CRS,并且事先难以接受初始药物治疗并被选为FESS。结果:U CRSsNP组术前和术后SNOT-22评分在术前和术后SNOT-22评分上有更高的显着性改善(37.13±9.393 vs 14.11±8.531),并且B CRSsNP组[41.76±±6.949对18.57±±8.495]。在U CRSsNP组中,术前SNOT-22得分高于20分的患者获得MCID的比例为88%。对于另一组,术前SNOT-22得分高于40分的患者在66%的患者中获得了MCID。多元logistic回归模型发现术前预测因素对QOL结局有影响。结论本研究结果提示,术前SNOT-22评分在U CRSsNP的患者在10到19之间,术前SNOT-22评分在B CRSsNP的患者之间。 FESS后,10和19或20-29不可能实现MCID改善。此外,与CRS的单方面特征不同,SNOT-22的术前流变学症状和术前心理功能障碍域是预测FESS后病情好转的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号